LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kumar, Pooja S"
  2. AU="Ejzak L."
  3. AU="Sisti, M"
  4. AU="White, B."
  5. AU=Gaeta Christopher
  6. AU="Zhou, Tony"
  7. AU=Haji Jumana Yusuf AU=Haji Jumana Yusuf
  8. AU="O'Neill, Anne"
  9. AU="Dima, Maria"
  10. AU="Hu, Jize"
  11. AU="Park, Eun Chan" AU="Park, Eun Chan"
  12. AU="Kwon, DeokKyu"
  13. AU="Szabo, Istvan Adorjan"
  14. AU="Pasdeloup, David"
  15. AU="Baikova, Olga Y"
  16. AU="Woo-Do Lee"
  17. AU="Dubouchaud, Hervé"

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Evaluation of bleeding events in patients receiving acalabrutinib therapy.

    Kumar, Pooja S / Wiczer, Tracy / Rosen, Lindsay / Pollauf, Arthur J / Zheng, Amy / Palettas, Marilly / Azali, Leylah / Bhat, Seema A / Byrd, John C / Grever, Michael R / Rogers, Kerry A / Woyach, Jennifer A / Kittai, Adam S

    Leukemia

    2023  Band 37, Heft 7, Seite(n) 1554–1557

    Mesh-Begriff(e) Humans ; Benzamides/adverse effects ; Pyrazines/adverse effects ; Leukemia, Lymphocytic, Chronic, B-Cell/chemically induced
    Chemische Substanzen acalabrutinib (I42748ELQW) ; Benzamides ; Pyrazines
    Sprache Englisch
    Erscheinungsdatum 2023-03-17
    Erscheinungsland England
    Dokumenttyp Research Support, Non-U.S. Gov't ; Letter
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-023-01869-1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy.

    Kumar, Pooja S / Wiczer, Tracy / Rosen, Lindsay / Pollauf, Arthur J / Zheng, Amy / Palettas, Marilly / Azali, Leylah / Bhat, Seema A / Byrd, John C / Grever, Michael R / Rogers, Kerry A / Woyach, Jennifer A / Kittai, Adam S

    Leukemia

    2023  Band 37, Heft 7, Seite(n) 1588

    Sprache Englisch
    Erscheinungsdatum 2023-05-25
    Erscheinungsland England
    Dokumenttyp Published Erratum
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-023-01927-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.

    Kumar, Pooja S / Saphire, Maureen L / Grogan, Madison / Benedict, Jason / Janse, Sarah / Agne, Julia L / Bertino, Erin M / Presley, Carolyn J

    Journal of pain & palliative care pharmacotherapy

    2021  Band 35, Heft 2, Seite(n) 91–99

    Abstract: Oncology and Palliative Medicine lack guidance on routine opioid risk screening and compliance monitoring. This study explored relationships among risk screening and aberrant medication related behaviors in patients with advanced lung cancer receiving ... ...

    Abstract Oncology and Palliative Medicine lack guidance on routine opioid risk screening and compliance monitoring. This study explored relationships among risk screening and aberrant medication related behaviors in patients with advanced lung cancer receiving embedded palliative care. This was a single center, prospective study and data was collected from December 2018 to March 2020. At the initial palliative visit, patients provided a baseline urine drug screen (UDS) test and completed the Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R) self-assessment. Clinical pharmacists provided comprehensive review and interpretation of UDS results. Among 39 patients, 12 (30.8%) scored positive for risk of aberrant medication behaviors on the SOAPP-R. Only 34 of 39 patients provided a baseline UDS test and were included in further analysis. Prior to pharmacist review, 11/11 (100%) baseline UDS results in the positive-risk group and 13/23 (56.5%) in the negative-risk group appeared unexpected (
    Mesh-Begriff(e) Analgesics, Opioid/adverse effects ; Humans ; Lung Neoplasms/drug therapy ; Opioid-Related Disorders/drug therapy ; Palliative Care ; Prospective Studies ; Risk Assessment ; Substance Abuse Detection
    Chemische Substanzen Analgesics, Opioid
    Sprache Englisch
    Erscheinungsdatum 2021-05-19
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2078852-6
    ISSN 1536-0539 ; 1536-0288
    ISSN (online) 1536-0539
    ISSN 1536-0288
    DOI 10.1080/15360288.2021.1920545
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang